In AD mouse models, pathophysiological changes, such as anti-apoptotic effects, reduced Aβ deposition and phosphorylated hippocampal tau, protection from synapse loss, reduced inflammatory and oxidative stress response in the cortex and hippocampus, and increased BDNF have been observed [119–121]. Here, MAPT is linked to Alzheimer disease.